Clinical Trial Update: The Efficacy of Topical Vaginal Oxytocin Gel in Postmenopausal Women With Vulvovaginal Atrophy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy of a topical vaginal oxytocin gel for vulvovaginal atrophy in postmenopausal women; the study is currently not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genitourinary Syndrome of Menopause
• Vaginal Atrophy
• Vulvar Atrophy

Drugs mentioned

• Topical vaginal oxytocin gel (oxytocin)

Snippet

Sponsor: Oxagon | Conditions: Vaginal Atrophy, Genitourinary Syndrome of Menopause | Phase 3 | Status: NOT_YET_RECRUITING